↓ Cooling
Business
FDA’s New Leadership Aims to Overhaul Rare Disease Approvals
FDA’s new Rare Disease Framework Initiative seeks to modernize approvals for therapies targeting ultra‑small patient groups.
Arcprogram
1 trends tracked about this subject — the full history, oldest to newest below.